# Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)

> **NCT01002911** · PHASE3 · COMPLETED · sponsor: **Population Health Research Institute** · enrollment: 500 (actual)

## Conditions studied

- Arrythmias

## Interventions

- **DRUG:** Cefazolin, Bacitracin, Cefalexin
- **DRUG:** Cefazolin

## Key facts

- **NCT ID:** NCT01002911
- **Lead sponsor:** Population Health Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-12
- **Primary completion:** 2012-01
- **Final completion:** 2012-01
- **Target enrollment:** 500 (ACTUAL)
- **Last updated:** 2013-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01002911

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01002911, "Prevention of Arrhythmia Device Infection Trial (PADIT Pilot)". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01002911. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*